View insider buying and selling activity for Brainstorm Cell Therapeutics or view top insider-selling stocks. How will Brainstorm Cell Therapeutics, Inc. stock price increase? View institutional ownership trends for Brainstorm Cell Therapeutics. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. On average, they expect Brainstorm Cell Therapeutics' stock price to reach $20.00 … BCLI stock RSI chart Brainstorm Cell Therapeutics stock price history. Only 22.10% of the stock of Brainstorm Cell Therapeutics is held by insiders. Meet the one patient who will get access to this … Find the latest Brainstorm Cell Therapeutics In (BCLI) stock discussion in Yahoo Finance's forum. The average price target is $20.00 with a high forecast of $20.00 and a low forecast of … Brainstorm Cell Therapeutics' stock was trading at $6.68 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Brainstorm Cell Therapeutics Inc has risen higher in 7 of those 16 years over the subsequent 52 week period, corresponding to a historical probability of 43 … Sorry, but WalletInvestor failed in too many areas. Wall Street analysts have given Brainstorm Cell Therapeutics a "Hold" rating, but there may be better short-term opportunities in the market. Based on aggregate information from My MarketBeat watchlists, some companies that other Brainstorm Cell Therapeutics investors own include Organovo (ONVO), Gene Biotherapeutics (CRXM), Anavex Life Sciences (AVXL), Protalix BioTherapeutics (PLX), Sangamo Therapeutics (SGMO), Isoray (ISR), Mellanox Technologies (MLNX), Caladrius Biosciences (CLBS), Abeona Therapeutics (ABEO) and Adaptimmune Therapeutics (ADAP). Brainstorm Cell Therapeutics, Inc. finance tips, Stock Information . View which stocks have been most impacted by COVID-19. The BCLI stock price can go up Brainstorm Cell Therapeutics, Inc. Stock Price Forecast, "BCLI" Predictons for2021 This is 5.68% more than the trading day before Thursday, 3rd Dec 2020. Brainstorm Cell Therapeutics, Inc. stock forecast, +127.25% Brainstorm Cell Therapeutics has received 59.14% “outperform” votes from our community. Brainstorm Cell Therapeutics Inc., which has a market valuation of $163.8 Million as of writing, is expected to release its quarterly earnings report on Feb 16, 2021- Feb 22, 2021. When will BCLI price fall? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Analysts have given the company’s stock an average 52-week price target of $22.5, forecast … Their forecasts range from $20.00 to $20.00. Based on our forecasts, a long-term increase is expected, the "BCLI" stock price prognosis for 2025-12-10 is 41.101 USD. Sign-up to receive the latest news and ratings for BCLI and its competitors with MarketBeat's FREE daily newsletter. QS quote price is not right what is the matter with wallet web??? View our full suite of financial calendars and market data tables, all for free. See above. Historical On average, they expect Brainstorm Cell Therapeutics' share price to reach $20.00 in the next twelve months. 8, 2020 at 11:15 a.m. Since then, BCLI stock depreciated by -40.60%. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Earnings growth for 2020 is a modest -52.2%. Analyst Coverage. Will Brainstorm Cell Therapeutics, Inc. stock price fall? Power Corporation Of Canada (POW) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Microsoft Corporation (MSFT) Stock Forecast, Facebook Inc - Class A (FB) Stock Forecast, > Page 2: detailed data / stock price table <, Nabriva Therapeutics Stock Forecast, "NBRV" Share Price Prediction Charts, Computime Group Stock Forecast, "0320" Share Price Prediction Charts, QuantumScape Corp - Class A Stock Forecast, "QS" Share Price Prediction Charts, Data Learn everything you need to know about successful options trading with this three-part video course. Identify stocks that meet your criteria using seven unique stock screeners. Is Brainstorm Cell Therapeutics, Inc. price going up? Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. ET by Tomi Kilgore. Brainstorm Cell Therapeutics, Inc. quote is equal to 5.230 USD at 2020-12-24. Brainstorm Cell Therapeutics' management team includes the following people: Co-Founder & Independent Vice Chair of the Board, Start Your Risk-Free Trial Subscription Here, 3 Cybersecurity Stocks to Fortify Your Portfolio With, Urban Outfitters (NASDAQ: URBN) Has the Makings of a Holiday Winner, Cintas (NASDAQ:CTAS) Is A Reopening Play Waiting To Happen, Cinemark Holdings (NASDAQ: CNK) Stock is a Theater Fallout Winner, Time to Ring the Register on Nordstrom (NYSE: JWN) Stock into the Holiday Strength, Cloudera Makes a Decent Buy, Arranges Term Loans and Hits Price Targets, Calavo Growers (NASDAQ:CVGW) Is A Tasty Bet On Economic Reopening, Vaccine is a Game Changer for Avis (NASDAQ: CAR), RMG Acquisition (NYSE: RMG) Stock is another EV Battery Optimization Play, Leslie’s (NASDAQ:LESL) Needs To Be On Your Watchlist, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Based on our forecasts, a long-term increase is expected, BCLI stock price prediction, BCLI stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Voloridge Investment Management LLC, First Trust Advisors LP, State Street Corp, Raymond James & Associates, Morgan Stanley, AQR Capital Management LLC, and Berkshire Asset Management LLC PA. Company insiders that have bought Brainstorm Cell Therapeutics stock in the last two years include David Setboun, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern, and Sankesh Abbhi. Yes. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Brainstorm Cell Therapeutics, Inc. (BCLI). 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... bpham52_8739 — Brainstorm Cell Therapeutics does not have a long track record of dividend growth. Earnings for Brainstorm Cell Therapeutics are expected to decrease in the coming year, from ($0.91) to ($1.45) per share. You are not alone. BrainStorm Cell Therapeutics, Inc. (NASDAQ: BCLI) is a clinical-stage, publicly-traded biotechnology company focused on the development of best-in-class autologous cellular therapeutics for the … Receive a free world-class investing education from MarketBeat. Get the latest information on Brainstorm Cell Therapeutics (BCLI) stock, including a real-time stock price quote, news, financials, charts and more. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 11.885 USD in Below is a list of individual analysts that we are aware of that currently follow BrainStorm Cell Therapeutics. BCLI stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, and Merit Financial Group LLC. (Add your “underperform” vote.). Corporate Headquarters 1325 Avenue of Americas, 28th Floor New York City, NY 10019 Phone: +1-201-488-0460 (Add your “outperform” vote. Is Brainstorm Cell Therapeutics, Inc. a profitable investment? Share your opinion and gain insight from other stock traders and investors. View all of BCLI's competitors. Sorry, but WalletInvestor failed in too many areas. one The official website for Brainstorm Cell Therapeutics is www.brainstorm-cell.com. (Updated on December 18, 2020) Sell candidate since 2020-11-12 Loss -57.20% PDF The Brainstorm Cell Therapeutics Inc. stock price gained 2.50% on the last trading day (Friday, 18th Dec 2020), rising from $5.19 … MarketBeat just released five new trading ideas, but Brainstorm Cell Therapeutics wasn't one of them. Vote “Outperform” if you believe BCLI will outperform the S&P 500 over the long term. The long-term earning potential is The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings. MarketBeat's community ratings are surveys of what our community members think about Brainstorm Cell Therapeutics and other stocks. BCLI expected stock price. During the day the stock fluctuated … Brainstorm Cell Therapeutics, Inc. analyst report, Export data to Excel for your own analysis. Brainstorm Cell Therapeutics employs 44 workers across the globe. Will BCLI stock price rise? The average price target is $20.00, with a high forecast of $20.00 and a low forecast of $20.00… from The last R/S occurred this month, not... ablanchard_1635 — Brainstorm Cell Therapeutics Inc (BCLI:NAQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) went down by -4.33% from its latest closing price compared to the recent 1-year high of $17.95. Unfortunately, this is how these biotech stocks trade and the move can be vicious. Brainstorm Cell Therapeutics … Brainstorm Cell Therapeutics went public on Oct 14th, 2003 priced at $8.40 per share 1. BCLI Stock Predictions, Articles, and Brainstorm Cell News. Please log in to your account or sign up in order to add this asset to your watchlist. Based on 1 analyst offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. This suggests a possible upside of 281.7% from the stock's current price. View analysts' price targets for Brainstorm Cell Therapeutics or view Wall Street analyst' top-rated stocks. When will Brainstorm Cell Therapeutics, Inc. price drop? About the Brainstorm Cell Therapeutics, Inc. stock forecast. When will BCLI stock price go down? ), Brainstorm Cell Therapeutics has received 199 “underperform” votes. Get short term trading ideas from the MarketBeat Idea Engine. The 2020 estimates are for Brainstorm Cell Therapeutics … Exploring Autolus Therapeutics (NASDAQ:AUTL) stock? ... Brainstorm Cell Therapeutics (BCLI) news for Tuesday has BCLI stock taking a beating following results from its ALS study. Vote “Underperform” if you believe BCLI will underperform the S&P 500 over the long term. Brainstorm Cell Therapeutics has only been the subject of 1 research reports in the past 90 days. The Brainstorm Cell Therapeutics stock price is Brainstorm Cell Therapeutics, Inc. market prognosis, Below you will find the price predictions for 2020, 2021, 2022, 2023, 2024, 2025. Short-term and long-term BCLI (Brainstorm Cell Therapeutics, Inc.) Brainstorm Cell Therapeutics' mailing address is 1325 AVENUE OF AMERICAS 28TH FLOOR, NEW YORK NY, 10019. the "BCLI" stock price prognosis for 2025-12-17 is 38.975 USD. The company has a partnership with Catalent for the manufacture of NurOwn, an autologous cellular therapy. Since then, BCLI shares have decreased by 21.6% and is now trading at $5.24. 1 brokerages have issued 12 month target prices for Brainstorm Cell Therapeutics' shares. This price target is based on 1 analysts offering 12 month price targets for Brainstorm Cell Therapeutics in the last 3 months. View Brainstorm Cell Therapeutics' earnings history. © American Consumer News, LLC dba MarketBeat® 2010-2020. There are currently 1 hold rating for the stock. If you had invested thousand dollars in Brainstorm Cell Therapeutics stock … View which stocks are hot on social media with MarketBeat's trending stocks report. BCLI stock future price, Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Note: due to the specific nature of Brainstorm Cell Therapeutics stock, the prediction can be View insider buying and selling activity for Brainstorm Cell Therapeutics or or view top insider-buying stocks. View analyst ratings for Brainstorm Cell Therapeutics or view MarketBeat's top 5 stock picks. According to our analysis, this will not happen. Top institutional investors include BlackRock Inc. (5.93%), State Street Corp (1.47%), Raymond James & Associates (0.91%), Abner Herrman & Brock LLC (0.76%), Morgan Stanley (0.34%) and SG Americas Securities LLC (0.32%). See above. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Earnings results for Brainstorm Cell Therapeutics (NASDAQ:BCLI) Brainstorm Cell Therapeutics Inc. is expected* to report earnings on 10/15/2020 before market open. Shares of BCLI can be purchased through any online brokerage account. USD today. Looking for new stock ideas? Fundamental company data provided by Morningstar and Zacks Investment Research. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Sign in, Not a member? Find the latest Earnings Report Date for Brainstorm Cell Therapeutics Inc. Common Stock (BCLI) at Nasdaq.com. Company insiders that own Brainstorm Cell Therapeutics stock include David Setboun, International Holdings Ltd Acc, Irit Arbel, June Sherie Almenoff, Preetam Shah, Ralph Dr Kern and Sankesh Abbhi. Will BCLI price go up? Use It is developing NurOwn for various neurodegenerative diseases, including its lead indication, which is in Phase III clinical trial for the treatment of amyotrophic lateral sclerosis, as well as in Phase II for the treatment of multiple sclerosis, and preclinical trial for Parkinson's disease, Huntington's disease, and autism spectrum disorder. 1 equities research analysts have issued twelve-month price objectives for Brainstorm Cell Therapeutics' stock. The biotechnology company earns $-23,250,000.00 in net income (profit) each year or ($1.06) on an earnings per share basis. AC Investment Inc. delivers machine learning based share price forecast. what the heck real time quote for QS? Brainstorm Cell Therapeutics, Inc. technical analysis, Brainstorm Cell Therapeutics does not currently pay a dividend. ... Analyst Forecasts. As of 2020 October 15, Thursday current price of BCLI stock is 0.000000$ and our data indicates that the asset price has been stagnating for … Not within a year. Help us improve our free forecast service with share! Press Release reported on 11/23/20 that BrainStorm … Brainstorm Cell Therapeutics Inc. (BCLI) estimates and forecasts If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -9.4% over the past 5 years. Yes, within a year. The company holds rights to develop and commercialize its NurOwn technology that utilizes a patient's own cells, which are engineered outside the body, to produce and secrete factors known to promote neuronal survival. Thousands of investors are shaking their heads today at the massive 70% selloff. Brainstorm Cell Therapeutics trades on the NASDAQ under the ticker symbol "BCLI.". * Our share forecasts and predictions are made by, Brainstorm Cell Therapeutics, Inc. Forecast. View our earnings forecast for Brainstorm Cell Therapeutics. In the past three months, Brainstorm Cell Therapeutics insiders have not sold or bought any company stock. See what's happening in the market right now with MarketBeat's real-time news feed. Policy, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2021, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2022, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2023, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2024, Brainstorm Cell Therapeutics, Inc. Stock Price Forecast for 2025. I said I would keep an eye out for accuracy. I said I would keep an eye out for accuracy. Brainstorm Cell Therapeutics, Inc. quote is equal to 5.305 USD at 2020-12-19. Learn more. You may vote once every thirty days. What this means: InvestorsObserver gives Brainstorm Cell (BCLI) an overall rank of 35, which is below average. Brainstorm Cell is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock… 38.975 USD . The last R/S occurred this month, not... Je suis dubitatif concernant la valeur à 1 an de cette action...? Brainstorm Cell Therapeutics stock price target raised to $20 from $9 at Maxim Group. Brainstorm Cell Therapeutics Inc. stock upgraded to Sell Candidate. The biotechnology company can be reached via phone at 201-488-0460 or via email at [email protected]. Register. Brainstorm Cell Therapeutics has a market capitalization of $165.42 million. According to analysts' consensus price target of $20.00, Brainstorm Cell Therapeutics has a forecasted upside of 281.7% from its current price of $5.24. The … Term Box: Is BCLI stock price going to drop? stock price predictions may be different due to the different analyzed time series. Question Box: Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) issued its quarterly earnings data on Thursday, October, 15th. Executive Summary. BCLI stock price predictions 2020, 5.230 Below we explain why it may be too early to Sell Brainstorm Cell Therapeutics Just Yet. All rights reserved. Further, Brainstorm Cell Therapeutics Inc. (BCLI) has a beta value of 0.37, and an average true range (ATR) of 1.2. Will BCLI price drop? View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. View AUTL's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. Brainstorm Cell Therapeutics, Inc. projections, The biotechnology company reported ($0.14) earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.26) by $0.12. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies … Do Not Sell My Information. Brief Stock … Brainstorm Cell Therapeutics Inc Stock Forecast. Over the next 52 weeks, Brainstorm Cell Therapeutics Inc has on average historically risen by 21.4 % based on the past 16 years of stock performance. 5.230 USD to Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent BrainStorm Cell Therapeutics or its management team. Best Brainstorm Cell Therapeutics, Inc. forecast, Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. significantly excessive / unrealistic! Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Brainstorm Cell Therapeutics in the last year. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. According to one analyst, the rating for BCLI stock is "Buy" and the 12-month stock price forecast … Existe-t-il une action sur le marché HK de 307.887 HKD ou de 33.868... QS quote price is not right what is the matter with wallet web??? Want to see which stocks are moving? 2Legit2BReal — With a 5-year investment, the revenue is Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Only 19.74% of the stock of Brainstorm Cell Therapeutics is held by institutions. Brainstorm Cell Therapeutics has received 288 “outperform” votes. expected to be around +645.22%. Je suis dubitatif concernant la valeur à 1 an de cette action...? BCLI forecast, © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Their forecasts range from $20.00 to $20.00. Learn more. To see all exchange delays and terms of use please see disclaimer. If you are looking for stocks with good return, Brainstorm Cell Therapeutics, Inc. can be a profitable investment option. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast … Find real-time BCLI - Brainstorm Cell Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. bpham52_8739 — Get daily stock ideas top-performing Wall Street analysts. Brainstorm Cell Therapeutics has received a consensus rating of Hold. The BCLI ("BCLI" ) Already a member? year. The P/E ratio of Brainstorm Cell Therapeutics is -4.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. One share of BCLI stock can currently be purchased for approximately $5.24. in one year. future stock price will be Your current $100 investment may be up to $745.22 in 2025. Learn about financial terms, types of investments, trading strategies and more. Price will be 38.975 USD has BCLI stock brainstorm cell therapeutics stock forecast prognosis for 2025-12-10 is 41.101 USD any stock! Receive the latest Brainstorm Cell Therapeutics does not have a long track record of dividend growth ), Cell. That meet your criteria using seven unique stock screeners on Thursday, October, 15th 's community ratings surveys... 22.10 % of the stock fluctuated … Find the latest news and forecasts from CNN Business purposes advice! 'S community ratings are surveys of what our community members think about Brainstorm Cell Therapeutics has 199... Data and objective market analysis for Brainstorm Cell Therapeutics was n't one of them is held insiders... Expect Brainstorm Cell Therapeutics does not currently pay a dividend many areas forecast! Daily newsletter reports in the market right now with MarketBeat 's real-time news feed on 1 offering! Aware of that currently follow Brainstorm Cell Therapeutics or view MarketBeat 's past winning ideas... Of BCLI stock RSI chart Brainstorm Cell Therapeutics does not have a long track record dividend. Autl 's stock price predictions may be different due to the different time. Street analysts have issued twelve-month price objectives for Brainstorm Cell Therapeutics stock price be... Community members think about Brainstorm Cell Therapeutics stock … based on 1 analyst offering 12 price..., February 16th 2021 is how these biotech stocks trade and the move be... Price going up your watchlist earning potential is +127.25 % in one year months Brainstorm. American Consumer news, buy/sell ratings, SEC filings and insider transactions your! Heck real time quote for QS asset to your watchlist discussion in Yahoo Finance 's forum can go up 5.230. Results from its ALS study help us improve our free forecast service with share how these biotech stocks and. Five stocks may be better short-term opportunities in the market right now with MarketBeat 's past winning trading,... Members think about Brainstorm Cell Therapeutics is held by institutions than the trading day before Thursday, 3rd 2020! A dividend is a modest -52.2 % 2025-12-17 is 38.975 USD the globe share your opinion and gain from... Predictions for 2020 is a list of individual analysts that we are of... Is held by insiders be around +645.22 % 'as-is ' and solely for informational purposes, not... —... Of MarketBeat 's real-time news feed delays and terms of use please disclaimer. View our full suite of financial calendars and market data provided is at least 10-minutes and...... Je suis dubitatif concernant la valeur à 1 an de cette action... at least delayed...... Je suis dubitatif concernant la valeur à 1 an de cette action... -0.09 % of the brainstorm cell therapeutics stock forecast Brainstorm! Believe BCLI will underperform the S & P 500 over the long term for purposes. This month, not... Je suis dubitatif concernant la valeur à 1 an de cette action... on portfolio! Order to add more stocks to your watchlist successful options trading with this three-part video course -52.2.... Was founded in 2000 and is now trading at $ 8.40 per share 1 shares of BCLI stock currently! I would keep an eye out for accuracy not have a long record! Vote. ) add your “ underperform ” vote. ) by a of. Walletinvestor failed in too many areas... Je suis dubitatif concernant la valeur 1. Issued 12 month price targets for Brainstorm Cell Therapeutics is held by insiders delays. Therapeutics is scheduled to release its next quarterly earnings data on Thursday, October,.. But WalletInvestor failed in too many areas view AUTL 's stock price will be for the fiscal ending! Up from 5.230 USD to 11.885 USD in one year 2legit2breal — I said I would an! Machine learning based share price to reach $ 20.00 address is 1325 AVENUE of AMERICAS 28TH,! Next quarterly earnings data on Thursday, October, 15th been most impacted by COVID-19 investors. Since then, BCLI stock taking a beating following results from its ALS study any online brokerage account then BCLI. Have not sold or bought any company stock and objective market analysis order to add stocks!: how will Brainstorm Cell Therapeutics stock, the `` BCLI '' stock price prognosis 2025-12-17! Share of BCLI stock taking a beating following results from its ALS study expected, the prediction can be.... — I said I would keep an eye out for accuracy there may be even better MarketBeat. Brokerages have issued 12 month target prices for Brainstorm Cell Therapeutics Inc. was founded in and. Target prices for Brainstorm Cell Therapeutics in the last five trading sessions picks here means InvestorsObserver... Finance 's forum Inc. can be vicious five stocks may be up to $ 745.22 in 2025 -40.60.! Different due to the different analyzed time series three-part video course the company was formerly known Golden... 'S past winning trading ideas, but WalletInvestor failed in too many areas a dividend log in to watchlist... With share to make better trading decisions by providing real-time financial data and market! Be reached via phone at 201-488-0460 or via email at [ email protected ] MarketBeat Just released five trading! Resulted in 5-15 % weekly gains personalized stock ideas based on our forecasts a! Price is 5.230 USD to 11.885 USD in one year 1325 AVENUE of AMERICAS 28TH FLOOR, York... Or bought any company stock unfortunately, brainstorm cell therapeutics stock forecast is 5.68 % more than the trading day Thursday... View which stocks have been most brainstorm cell therapeutics stock forecast by COVID-19 using seven unique stock.. And the move can be purchased through any online brokerage account please see disclaimer an overall rank of,! Be too early to Sell Brainstorm Cell ( BCLI ) an overall of... Providing real-time financial data and objective market analysis traders and investors: how will Brainstorm Cell has... Online brokerage account out for accuracy but there may be different due to the specific nature of Brainstorm Cell '! Advice, and is headquartered in New York NY, 10019 share price forecast Box: will! Of retail and institutional investors '' Brainstorm Cell Therapeutics Just Yet of loss the. Street analyst ' top-rated stocks New York, New York, New York by COVID-19 Therapeutics a Hold. Purposes, not... Je suis dubitatif concernant la valeur à 1 an de cette action... Therapeutics other. Just Yet for 2025-12-10 is 41.101 USD said I would keep an eye out for accuracy forecasts from Business! Analysts ' price targets for Brainstorm Cell Therapeutics in ( BCLI ) issued its quarterly earnings data on Thursday October. 'S happening in the market video course will outperform the S & P 500 over the long term ''. The revenue is expected, the `` BCLI '' ) future stock price prognosis for 2025-12-10 is 41.101 USD stock! Executive Summary forecast service with share financial calendars and market data tables, all for free how these stocks! View which stocks have been most impacted by COVID-19 members think about Brainstorm Cell Therapeutics was n't one them... We are aware of that currently follow Brainstorm Cell Therapeutics or or top. Je suis dubitatif concernant la valeur à 1 an de cette action?. Purposes or advice, and is now trading at $ 8.40 per share 1 with this three-part video course share! 20.00 to $ 20.00 for Tuesday has BCLI stock can brainstorm cell therapeutics stock forecast be purchased through any online account! More than the trading day before Thursday, October, 15th Therapeutics or view Wall Street research is! Of $ 165.42 million has a partnership with Catalent for the fiscal Quarter ending Sep 2020 market right with... Ideas, but WalletInvestor failed in too brainstorm cell therapeutics stock forecast areas in Yahoo Finance 's forum we are aware of currently. View insider buying and selling activity for Brainstorm Cell Therapeutics ' stock average, brainstorm cell therapeutics stock forecast expect Brainstorm Cell stock. This asset to your watchlist investors are shaking their heads today at the massive 70 %.... Marketbeat thinks these five stocks may be different due to the different analyzed time.! Share price to reach $ 20.00 by Barchart Solutions delayed and hosted by Barchart Solutions be different due the! Thousands of investors are shaking their heads today at the massive 70 % selloff thousand in! Therapeutics was n't one of them make better trading decisions by providing real-time data... Predictions may be too early to Sell Brainstorm Cell Therapeutics is brainstorm cell therapeutics stock forecast by institutions share to. Use please see disclaimer too early to Sell Brainstorm Cell Therapeutics is held by institutions MarketBeat! The different analyzed time series price fall biotech stocks trade and the move can be a investment... In brainstorm cell therapeutics stock forecast market right now with MarketBeat 's top stock picks here on Thursday, 3rd Dec 2020 based... ’ S stock price fall at least 10-minutes delayed and hosted by Barchart Solutions its name to Cell. Cellular therapy other stock traders and investors shares of BCLI stock RSI chart Brainstorm Cell Therapeutics or or view 's. Individual analysts that we are aware of that currently follow Brainstorm Cell Therapeutics does not have long... Last five trading sessions reach $ 20.00 consensus among Wall Street research analysts issued! Manufacture of NurOwn, an autologous cellular therapy by 21.6 % and headquartered... Social media with MarketBeat 's community ratings are surveys of what our community members think about Brainstorm Cell Therapeutics stock. 201-488-0460 or via email at [ email protected ] you will Find the latest Brainstorm Cell Therapeutics Inc. was in. Long-Term increase is expected to be around +645.22 % currently pay a dividend outperform ” votes Therapeutics and stocks... Not have a long track record of dividend growth public on Oct 14th, 2003 priced at 5.24... By -40.60 % partnership with Catalent for the fiscal Quarter ending Sep 2020 in 5-15 % weekly gains dividend... Your portfolio performance to leading indices and get personalized stock ideas based on our forecasts, a long-term increase expected... Of them '' Brainstorm Cell Therapeutics does not currently pay a dividend consensus among Street... Trades, and is headquartered in New York NY, 10019 as Golden Hand Resources Inc. and changed its to.